View:
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported) May 4, 2004
PEDIATRIX MEDICAL GROUP, INC.
-----------------------------
(Exact Name of Registrant as Specified in its Charter)
FLORIDA 0-26762 65-0271219
------- ------- ----------
(State or Other Jurisdiction (Commission (IRS Employer
of Incorporation) File Number) Identification No.)
1301 Concord Terrace
Sunrise, Florida 33323-2825
---------------------------
(Address of Principal Executive Offices, Including Zip Code)
Registrant's Telephone Number, Including Area Code: (954) 384-0175
(Former Name or Former Address, if Changed Since Last Report)
Item 12. Results of Operations and Financial Condition
On May 4, 2004, Pediatrix Medical Group, Inc. issued a press release announcing
its results of operations for the three months ended March 31, 2004. A copy of
the press release is attached as Exhibit 99.1 and is incorporated herein by
reference.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
PEDIATRIX MEDICAL GROUP, INC.
Date: May 4, 2004 By: /s/ Karl B. Wagner
-----------------------------
Karl B. Wagner
Chief Financial Officer
EXHIBIT INDEX
-------------
EXHIBIT NO. DESCRIPTION
- ----------- -----------
99.1 Press Release dated May 4, 2004.
Exhibit 99.1
Pediatrix Earns 85 Cents Per Share on Record Quarterly Revenue
FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--May 4, 2004--Pediatrix
Medical Group, Inc. (NYSE:PDX), the nation's largest provider of
physician services focused on newborn and maternal-fetal care, today
reported continued strong revenue and earnings growth and expanded
operating margins for the three months ended March 31, 2004.
Highlights for the 2004 first quarter include:
-- Earnings per share of 85 cents, up 25 percent from the
comparable prior period;
-- Record quarterly revenue of $148.1 million, an increase of 17
percent over the prior-year period;
-- Strong same-unit revenue growth of 9.7 percent;
-- Operating income of $34.1 million with operating margin
expansion of more than 116 basis points, to 23 percent; and
-- Net income of $21.3 million, an increase of 25 percent over
the prior-year period.
"This was another good quarter in which we continued to combine
growth with increased operating efficiencies to produce superior
results," said Roger J. Medel, M.D., President and Chief Executive
Officer of Pediatrix Medical Group, Inc. "We're successfully executing
our expansion strategy and we're pleased by the number of physicians
who continue to join our national group practice."
First quarter 2004 revenue was $148.1 million, up 17 percent from
$126.2 million for the comparable period. This increase reflects
same-unit revenue growth of 9.7 percent, as well as contributions from
acquisitions completed during 2003. Same-unit neonatal intensive care
patient volume increased by 3.6 percent for the 2004 first quarter.
Income from operations was $34.1 million for the 2004 first
quarter, up 24 percent from $27.6 million for the comparable period of
2003. Operating margin of 23 percent increased by 116 basis points for
the 2004 first quarter as a result of continued efficiencies at both
the practice and general and administrative levels.
Net income increased by 25 percent, to $21.3 million for the three
months ended March 31, 2004 from $17 million for the comparable period
of 2003. Pediatrix earned 85 cents per share, based on a weighted
average 25.1 million shares outstanding, up 25 percent from earnings
of 68 cents per share, based on a weighted average 25.1 million shares
outstanding for the three months ended March 31, 2003.
During the 2004 first quarter, Pediatrix used approximately $8.7
million of cash to acquire two physician practices, including a group
practice that provides neonatal and pediatric intensive care services
in Tallahassee, Florida, and a pediatric cardiology physician group
practice in Denver. Acquisitions continued in the 2004 second quarter
with the addition of a neonatal physician group practice based in
Lafayette, Louisiana, and a maternal-fetal medicine physician group
practice based in Atlanta, Georgia.
Pediatrix ended the 2004 first quarter with more than $24 million
in cash and cash equivalents, and total debt of approximately $2
million.
Earnings conference call
Pediatrix Medical Group, Inc. will host an investor conference
call to discuss the quarterly results at 10 a.m. (EDT) today. The
conference call Webcast may be accessed from the Company's Website,
www.pediatrix.com. A telephone replay of the conference call will be
available from 2 p.m. (EDT) today through midnight (EDT) May 11, 2004
by dialing 800-475-6701, access code 727627. The replay will also be
available at www.pediatrix.com.
About Pediatrix
Pediatrix was founded in 1979. Pediatrix physicians are reshaping
the delivery of maternal-fetal and newborn care, identifying best
demonstrated processes and participating in clinical research to
enhance patient outcomes and provide high-quality, cost-effective
care. Its neonatal physicians provide services at more than 200
neonatal intensive care units, and through Obstetrix, its
maternal-fetal physicians provide services in many markets where
Pediatrix's neonatal physicians practice. Combined, Pediatrix and its
affiliated professional corporations employ more than 700 physicians
in 31 states and Puerto Rico. Pediatrix is also the nation's largest
provider of newborn hearing screens and the largest private provider
of newborn metabolic screening. Additional information is available at
http://www.pediatrix.com .
Certain statements and information in this press release may be
deemed to be "forward-looking statements" within the meaning of the
Federal Private Securities Litigation Reform Act of 1995.
Forward-looking statements may include, but are not limited to,
statements relating to our objectives, plans and strategies, and all
statements (other than statements of historical facts) that address
activities, events or developments that we intend, expect, project,
believe or anticipate will or may occur in the future are
forward-looking statements. These statements are often characterized
by terminology such as "believe", "hope", "may", "anticipate",
"should", "intend", "plan", "will", "expect", "estimate", "project",
"positioned", "strategy" and similar expressions, and are based on
assumptions and assessments made by Pediatrix's management in light of
their experience and their perception of historical trends, current
conditions, expected future developments and other factors they
believe to be appropriate. Any forward-looking statements in this
press release are made as of the date hereof, and Pediatrix undertakes
no duty to update or revise any such statements, whether as a result
of new information, future events or otherwise. Forward-looking
statements are not guarantees of future performance and are subject to
risks and uncertainties. Important factors that could cause actual
results, developments, and business decisions to differ materially
from forward-looking statements are described in Pediatrix's most
recent Annual Report on Form 10-K, including the section entitled
"Risk Factors".
Pediatrix Medical Group, Inc.
Consolidated Statements of Income
(Unaudited)
Three Months Ended
March 31,
2004 2003
-------------------
(in thousands,
except for per
share data)
-------------------
Net patient service revenue $148,116 $126,200
--------- ---------
Operating expenses:
Practice salaries and benefits 86,475 74,616
Practice supplies and other operating expenses 5,351 4,065
General and administrative expenses 19,847 18,301
Depreciation and amortization 2,363 1,650
--------- ---------
Total operating expenses 114,036 98,632
--------- ---------
Income from operations 34,080 27,568
--------- ---------
Investment income 146 139
Interest expense (256) (290)
--------- ---------
Income before income taxes 33,970 27,417
Income tax provision (12,654) (10,418)
--------- ---------
Net income $21,316 $16,999
========= =========
Per share data:
Net income per common and common equivalent share
(diluted) $ 0.85 $ 0.68
Weighted average shares used in computing net
income per common and common equivalent share
(diluted) 25,105 25,091
Balance Sheet Highlights
------------------------
As of As of
Mar. 31, Dec. 31,
2004 2003
----------- -----------
(Unaudited)
($ in thousands)
Assets:
Cash and cash equivalents $24,314 $27,896
Accounts receivable, net 97,940 94,213
Other current assets 19,666 23,448
Other assets 580,612 572,037
----------- -----------
Total assets $722,532 $717,594
=========== ===========
Liabilities and shareholders' equity:
Accounts payable & accrued expenses
$ 75,470 $ 111,974
Total debt 2,046 1,864
Other liabilities 27,938 31,378
----------- -----------
Total liabilities 105,454 145,216
Shareholders' equity 617,078 572,378
----------- -----------
Total liabilities and shareholders' equity $ 722,532 $ 717,594
=========== ===========
CONTACT: Pediatrix Medical Group, Inc., Fort Lauderdale
Investors:
Bob Kneeley, 954-384-0175, x-5300
bob_kneeley@pediatrix.com